These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21718815)
1. Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine. Natarajan K; Xie Y; Nakanishi T; Beck WT; Bauer KS; Ross DD Biochim Biophys Acta; 2011 Jul; 1809(7):295-305. PubMed ID: 21718815 [TBL] [Abstract][Full Text] [Related]
2. Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1. Xie Y; Natarajan K; Bauer KS; Nakanishi T; Beck WT; Moreci RS; Jeyasuria P; Hussain A; Ross DD Biochim Biophys Acta; 2013 Dec; 1829(12):1288-99. PubMed ID: 24189494 [TBL] [Abstract][Full Text] [Related]
3. Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1. Natarajan K; Xie Y; Nakanishi T; Moreci RS; Jeyasuria P; Hussain A; Ross DD J Vis Exp; 2016 May; (111):. PubMed ID: 27286290 [TBL] [Abstract][Full Text] [Related]
4. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells. Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818 [TBL] [Abstract][Full Text] [Related]
5. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters. Zong Y; Zhou S; Fatima S; Sorrentino BP J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162 [TBL] [Abstract][Full Text] [Related]
6. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage. Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421 [TBL] [Abstract][Full Text] [Related]
7. Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway. Hamdan AM; Koyanagi S; Wada E; Kusunose N; Murakami Y; Matsunaga N; Ohdo S J Biol Chem; 2012 May; 287(21):17224-17231. PubMed ID: 22396548 [TBL] [Abstract][Full Text] [Related]
8. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells. Tompkins LM; Li H; Li L; Lynch C; Xie Y; Nakanishi T; Ross DD; Wang H Biochem Pharmacol; 2010 Dec; 80(11):1754-61. PubMed ID: 20804740 [TBL] [Abstract][Full Text] [Related]
9. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455 [TBL] [Abstract][Full Text] [Related]
10. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Wang H; Wu X; Hudkins K; Mikheev A; Zhang H; Gupta A; Unadkat JD; Mao Q Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1295-304. PubMed ID: 17082346 [TBL] [Abstract][Full Text] [Related]
11. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Manna PR; Dyson MT; Eubank DW; Clark BJ; Lalli E; Sassone-Corsi P; Zeleznik AJ; Stocco DM Mol Endocrinol; 2002 Jan; 16(1):184-99. PubMed ID: 11773448 [TBL] [Abstract][Full Text] [Related]
12. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196 [TBL] [Abstract][Full Text] [Related]
13. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance. Allen JD; Jackson SC; Schinkel AH Cancer Res; 2002 Apr; 62(8):2294-9. PubMed ID: 11956086 [TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C. González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304 [TBL] [Abstract][Full Text] [Related]
15. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice. Marchetti S; de Vries NA; Buckle T; Bolijn MJ; van Eijndhoven MA; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH Mol Cancer Ther; 2008 Aug; 7(8):2280-7. PubMed ID: 18723475 [TBL] [Abstract][Full Text] [Related]
16. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Bailey-Dell KJ; Hassel B; Doyle LA; Ross DD Biochim Biophys Acta; 2001 Sep; 1520(3):234-41. PubMed ID: 11566359 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. Calin-Jageman IE; Wang J; Bannon MJ J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation. Petropoulos S; Gibb W; Matthews SG Biol Reprod; 2011 Apr; 84(4):783-9. PubMed ID: 21159928 [TBL] [Abstract][Full Text] [Related]
20. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Zhou L; Naraharisetti SB; Wang H; Unadkat JD; Hebert MF; Mao Q Mol Pharmacol; 2008 Mar; 73(3):949-59. PubMed ID: 18079276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]